StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Sanofi (SAN:FP) (SNY) PT Raised to EUR96 at Societe Generale
September 23, 2019 7:12 AM
Societe Generale analyst Florent Cespedes ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst PT Change
Intl Ratings
Next Articles
Guggenheim Upgrades Sanofi (SAN:FP) (SNY) to Buy
September 23, 2019 6:16 AM
Morgan Stanley Upgrades Sanofi-Aventis (SNY) to Overweight
September 20, 2019 11:48 AM
Regeneron (REGN), Sanofi (SNY) Report Publication of Results from Two Positive Phase 3 Trials of Dupixent (dupilumab) in Severe Chronic Rhinosinusitis with Nasal Polyps
September 20, 2019 7:01 AM
Sanofi : CHMP recommends approval of Dupixent® (dupilumab) for severe chronic rhinosinusitis with nasal polyposis Â
September 20, 2019 6:48 AM
Regeneron (REGN) Announces CHMP Recommended Approval of Dupixent for Severe Chronic Rhinosinusitis with Nasal Polyposis
September 20, 2019 6:44 AM
